BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 34605010)

  • 1. Early manifestations of genetic risk for neurodevelopmental disorders.
    Askeland RB; Hannigan LJ; Ask H; Ayorech Z; Tesli M; Corfield E; Magnus P; Njølstad PR; Andreassen OA; Davey Smith G; Reichborn-Kjennerud T; Havdahl A
    J Child Psychol Psychiatry; 2022 Jul; 63(7):810-819. PubMed ID: 34605010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Genetic Risk Variants With Attention-Deficit/Hyperactivity Disorder Trajectories in the General Population.
    Riglin L; Collishaw S; Thapar AK; Dalsgaard S; Langley K; Smith GD; Stergiakouli E; Maughan B; O'Donovan MC; Thapar A
    JAMA Psychiatry; 2016 Dec; 73(12):1285-1292. PubMed ID: 27806167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrauterine Growth and Offspring Neurodevelopmental Traits: A Mendelian Randomization Analysis of the Norwegian Mother, Father and Child Cohort Study (MoBa).
    D'Urso S; Moen GH; Hwang LD; Hannigan LJ; Corfield EC; Ask H; Johannson S; Njølstad PR; Beaumont RN; Freathy RM; Evans DM; Havdahl A
    JAMA Psychiatry; 2024 Feb; 81(2):144-156. PubMed ID: 37878341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Language deficits in specific language impairment, attention deficit/hyperactivity disorder, and autism spectrum disorder: An analysis of polygenic risk.
    Nudel R; Christiani CAJ; Ohland J; Uddin MJ; Hemager N; Ellersgaard DV; Spang KS; Burton BK; Greve AN; Gantriis DL; Bybjerg-Grauholm J; Jepsen JRM; Thorup AAE; Mors O; Nordentoft M; Werge T
    Autism Res; 2020 Mar; 13(3):369-381. PubMed ID: 31577390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developmental milestones in early childhood and genetic liability to neurodevelopmental disorders.
    Hannigan LJ; Askeland RB; Ask H; Tesli M; Corfield E; Ayorech Z; Magnus P; Njølstad PR; Øyen AS; Stoltenberg C; Andreassen OA; Ronald A; Smith GD; Reichborn-Kjennerud T; Havdahl A
    Psychol Med; 2023 Apr; 53(5):1750-1758. PubMed ID: 37310338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychiatric Polygenic Risk Scores as Predictor for Attention Deficit/Hyperactivity Disorder and Autism Spectrum Disorder in a Clinical Child and Adolescent Sample.
    Jansen AG; Dieleman GC; Jansen PR; Verhulst FC; Posthuma D; Polderman TJC
    Behav Genet; 2020 Jul; 50(4):203-212. PubMed ID: 31346826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating attention-deficit hyperactivity disorder and autism spectrum disorder traits in the general population: What happens in adult life?
    Riglin L; Leppert B; Langley K; Thapar AK; O'Donovan MC; Davey Smith G; Stergiakouli E; Tilling K; Thapar A
    J Child Psychol Psychiatry; 2021 Apr; 62(4):449-457. PubMed ID: 32663329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations Between Pregnancy-Related Predisposing Factors for Offspring Neurodevelopmental Conditions and Parental Genetic Liability to Attention-Deficit/Hyperactivity Disorder, Autism, and Schizophrenia: The Norwegian Mother, Father and Child Cohort Study (MoBa).
    Havdahl A; Wootton RE; Leppert B; Riglin L; Ask H; Tesli M; Bugge Askeland R; Hannigan LJ; Corfield E; Øyen AS; Andreassen OA; Tilling K; Davey Smith G; Thapar A; Reichborn-Kjennerud T; Stergiakouli E
    JAMA Psychiatry; 2022 Aug; 79(8):799-810. PubMed ID: 35793100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Maternal Neurodevelopmental Risk Alleles With Early-Life Exposures.
    Leppert B; Havdahl A; Riglin L; Jones HJ; Zheng J; Davey Smith G; Tilling K; Thapar A; Reichborn-Kjennerud T; Stergiakouli E
    JAMA Psychiatry; 2019 Aug; 76(8):834-842. PubMed ID: 31042271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and phenotypic heterogeneity in early neurodevelopmental traits in the Norwegian Mother, Father and Child Cohort Study.
    Hegemann L; Corfield EC; Askelund AD; Allegrini AG; Askeland RB; Ronald A; Ask H; St Pourcain B; Andreassen OA; Hannigan LJ; Havdahl A
    Mol Autism; 2024 Jun; 15(1):25. PubMed ID: 38849897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic background to attention deficit and hyperactivity disorder and attention deficit and hyperactivity disorder symptoms at the age of 5 years: the role of sleep duration.
    Morales-Muñoz I; Paavonen EJ; Kantojärvi K; Härkänen T; Saarenpää-Heikkilä O; Kylliäinen A; Himanen SL; Paunio T
    Sleep; 2023 Jul; 46(7):. PubMed ID: 36861221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic risk for attention-deficit/hyperactivity disorder contributes to neurodevelopmental traits in the general population.
    Martin J; Hamshere ML; Stergiakouli E; O'Donovan MC; Thapar A
    Biol Psychiatry; 2014 Oct; 76(8):664-71. PubMed ID: 24673882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterizing Developmental Trajectories and the Role of Neuropsychiatric Genetic Risk Variants in Early-Onset Depression.
    Rice F; Riglin L; Thapar AK; Heron J; Anney R; O'Donovan MC; Thapar A
    JAMA Psychiatry; 2019 Mar; 76(3):306-313. PubMed ID: 30326013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polygenic risk for ADHD and ASD and their relation with cognitive measures in school children.
    Aguilar-Lacasaña S; Vilor-Tejedor N; Jansen PR; López-Vicente M; Bustamante M; Burgaleta M; Sunyer J; Alemany S
    Psychol Med; 2022 May; 52(7):1356-1364. PubMed ID: 32924895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inattention and hyperactivity/impulsivity among children with attention-deficit/hyperactivity-disorder, autism spectrum disorder, and intellectual disability.
    McClain MB; Hasty Mills AM; Murphy LE
    Res Dev Disabil; 2017 Nov; 70():175-184. PubMed ID: 28957735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pleiotropy between language impairment and broader behavioral disorders-an investigation of both common and rare genetic variants.
    Nudel R; Appadurai V; Buil A; Nordentoft M; Werge T
    J Neurodev Disord; 2021 Nov; 13(1):54. PubMed ID: 34773992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and associations with attention-deficit/hyperactivity disorder and autism spectrum disorder in children.
    Skogheim TS; Weyde KVF; Aase H; Engel SM; Surén P; Øie MG; Biele G; Reichborn-Kjennerud T; Brantsæter AL; Haug LS; Sabaredzovic A; Auyeung B; Villanger GD
    Environ Res; 2021 Nov; 202():111692. PubMed ID: 34293314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shared genetic influences between dimensional ASD and ADHD symptoms during child and adolescent development.
    Stergiakouli E; Davey Smith G; Martin J; Skuse DH; Viechtbauer W; Ring SM; Ronald A; Evans DE; Fisher SE; Thapar A; St Pourcain B
    Mol Autism; 2017; 8():18. PubMed ID: 28392908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autism spectrum disorder polygenic scores are associated with every day executive function in children admitted for clinical assessment.
    Torske T; Naerland T; Bettella F; Bjella T; Malt E; Høyland AL; Stenberg N; Øie MG; Andreassen OA
    Autism Res; 2020 Feb; 13(2):207-220. PubMed ID: 31571410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating the impact of transmitted and non-transmitted psychiatric and neurodevelopmental polygenic scores on youth emotional problems.
    Shakeshaft A; Martin J; Dennison CA; Riglin L; Lewis CM; O'Donovan MC; Thapar A
    Mol Psychiatry; 2024 Feb; 29(2):238-246. PubMed ID: 37990052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.